Eternal 10 adj. EBITDA 1.72B rupees -42% y/y

Eternal 10 adj. EBITDA 1.72B rupees -42% y/y

Generation Bio (GBIO) has announced a 1-for-10 reverse stock split, effective July 21, 2025. The move aims to increase the per-share market price to meet Nasdaq's minimum bid requirements. The outstanding shares will be reduced from approximately 67.3 million to 6.7 million, without altering the total number of authorized shares or the par value of the common stock. The stock will continue trading under the symbol "GBIO" but with a new CUSIP number, 37148K 209 [1].

The reverse stock split is a strategic financial maneuver to ensure compliance with Nasdaq listing standards. Generation Bio's shares had fallen below the required minimum, necessitating this action. Shareholders will not receive fractional shares; instead, those entitled to fractions will receive cash payments. Shareholders holding shares electronically need not take any action, while those owning shares through a bank or broker will see their positions adjusted automatically. This adjustment allows the company to maintain its position on the exchange while continuing its mission of developing treatments for autoimmune diseases [1].

The company's latest proxy statement and investor relations communications provide full details on the reverse stock split. This move is part of Generation Bio's efforts to meet Nasdaq listing requirements and ensure its compliance with exchange standards [1].

References:
[1] https://www.gurufocus.com/news/2987487/generation-bio-announces-1for10-reverse-stock-split-gbio-stock-news